News

Stemtech Corporation Announces Uplist to OTCQB, Maintains Focus on Expansion and Transparency

NAPLES, FL / ACCESSWIRE / September 4, 2024 / ("STEK") Stemtech Corporation, the pioneer and trailblazer in the stem cell…

1 year ago

Compassion Center Urges DEA to Reschedule Cannabis to Schedule III During December 2, 2024, Hearing

Compassion Center urges the DEA to reschedule cannabis to Schedule III of the Controlled Substances Act during the December 2,…

1 year ago

Sunknowledge Services Inc. Ensures Unparalleled Accuracy in its Medical Coding Services

Sunknowledge Services Inc. Sets the Gold Standard in Medical Coding Excellence, Enhancing Revenue Cycle Management for Healthcare Providers NEW YORK…

1 year ago

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry

Current Test Positivity Rate for Coronavirus Infection in the U.S. is 18%Development of a novel antiviral compound, XR8-23 (Compound 10),…

1 year ago

Revelstoke Capital Partners Announces Significant Growth Investment in MediQuant

DENVER, CO and INDEPENDENCE, OH / ACCESSWIRE / September 4, 2024 / Revelstoke Capital Partners ("Revelstoke"), a healthcare-focused private equity…

1 year ago

CBD Life Sciences, Inc. (CBDL) Unveils Mellow Mornings: A Revolutionary Nano CBD Coffee Creamer Set to Boost Revenue Amid Growing National Demand

SCOTTSDALE, AZ / ACCESSWIRE / September 4, 2024 / CBD Life Sciences, Inc. (OTC PINK:CBDL), a leader in the CBD…

1 year ago

Beta Bionics Announces Partnership With Abbott to Integrate the iLet Bionic Pancreas With the FreeStyle Libre 3 Plus iCGM

IRVINE, CA / ACCESSWIRE / September 4, 2024 / Beta Bionics, Inc., a pioneering leader in the development of advanced…

1 year ago

Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications

MIAMI, FL / ACCESSWIRE / September 4, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a pre-clinical-stage company…

1 year ago

As Research into Pain Accelerates, a Newly Recognized Type of Pain Comes to the Forefront – Tonix Targets it with FDA-Fast Track-Designated TNX-102 SL

CHATHAM, NJ / ACCESSWIRE / September 4, 2024 / This post was written and published as a collaboration between the…

1 year ago